(株)ヘリオスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4593/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2018/12/07 | 日証協 | 643,445株 | +5.06% | 382,445株 | -41.81% | 475,306株 | +0.15% | 27,100株 | -37.32% |
2018/11/30 | 日証協 | 612,445株 | -19.1% | 657,190株 | +70.16% | 474,606株 | -14.95% | 43,233株 | -19.14% |
2018/11/22 | 日証協 | 757,059株 | -5.21% | 386,226株 | -50.45% | 558,006株 | -4.64% | 53,467株 | +72.81% |
2018/11/16 | 日証協 | 798,658株 | -2.8% | 779,521株 | -0.28% | 585,176株 | -0.69% | 30,940株 | -18.15% |
2018/11/09 | 日証協 | 821,687株 | +93.72% | 781,709株 | +98.59% | 589,271株 | +7.36% | 37,800株 | +197.31% |
2018/11/02 | 日証協 | 424,162株 | -13.38% | 393,625株 | -50.5% | 548,865株 | -6.68% | 12,714株 | -25.26% |
2018/10/26 | 日証協 | 489,703株 | -48.27% | 795,260株 | -5.95% | 588,151株 | -11.56% | 17,012株 | -71.08% |
2018/10/19 | 日証協 | 946,725株 | +107.57% | 845,557株 | +1134.39% | 665,033株 | +9.74% | 58,832株 | +616.76% |
2018/10/12 | 日証協 | 456,100株 | -14.63% | 68,500株 | -8.59% | 605,995株 | +0.23% | 8,208株 | -25.38% |
2018/10/05 | 日証協 | 534,270株 | -4.39% | 74,937株 | +90.2% | 604,585株 | -1.21% | 11,000株 | -41.18% |
2018/09/28 | 日証協 | 558,829株 | -8.42% | 39,400株 | +27.51% | 611,991株 | -4.4% | 18,700株 | -43.85% |
2018/09/21 | 日証協 | 610,229株 | -1.29% | 30,900株 | -72.3% | 640,184株 | -0.73% | 33,306株 | +123.44% |
2018/09/14 | 日証協 | 618,229株 | -0.53% | 111,566株 | +74.59% | 644,878株 | -1% | 14,906株 | -22.44% |
2018/09/07 | 日証協 | 621,529株 | +2.71% | 63,900株 | -54.99% | 651,372株 | +2.02% | 19,219株 | -24.05% |
2018/08/31 | 日証協 | 605,129株 | -1.25% | 141,959株 | -52.08% | 638,453株 | -0.98% | 25,306株 | -6.62% |
2018/08/24 | 日証協 | 612,761株 | +6.75% | 296,258株 | +84.16% | 644,779株 | +1.92% | 27,100株 | +108.22% |
2018/08/17 | 日証協 | 574,029株 | -6.19% | 160,866株 | +6.63% | 632,647株 | -3.42% | 13,015株 | +6.68% |
2018/08/10 | 日証協 | 611,929株 | -2.69% | 150,859株 | +125.5% | 655,060株 | -1.34% | 12,200株 | -49.39% |
2018/08/03 | 日証協 | 628,829株 | -3.89% | 66,900株 | -28.68% | 663,960株 | -2.24% | 24,107株 | -10.75% |
※株式分割は考慮していませんのでご注意ください。
Page Top